FROM THE NEW YORK TIMES: A BETTER ALTERNATIVE TO STATINS?

  This story was in the headlines today. Merck finally got the results they were looking for on their drug Vytorin. Note that the drug did not lower plaque build-up and that all the subjects in the test were eating a low-fat / low-cholesterol diet. Vytorin (a combination of ezetimibe and…

Continue reading